Idera Pharmaceuticals Inc (IDRA)

[tedkov]

Idera Shareholders Upset Over Merger Bid - (via NewsPoints Desk)
January 22, 2018
Tags: NewsPoints Idera BioCryst United States Corporate Affairs Mergers &
Acquisitions

A group of Idera Pharmaceuticals shareholders are attempting
to block the purchase of the company by BioCryst Pharmaceuticals in its attempt to form a new company along with Idera Pharmaceuticals.

The shareholders allege that the purchase price in which Idera shareholders will receive 0.20 shares of the new company’s stock per share, while BioCryst shareholders will receive 0.50 shares of the new company’s stock per share, and where BioCryst shareholders will own 51.6% of the stock in the post-merger entity is insufficient in light of the company's growth prospects, and that deal-protection clauses in the merger agreement preclude other companies from submitting successful competing offers. In addition, shareholders allege that senior management obtained personal benefits for their own self interests in agreeing to sell the company that are not being shared with common stockholders.

Idera did not immediately respond to requests for a comment.
To contact the law firm on behalf of shareholders of
Idera for more information as to how you can participate with other shareholders for a higher price at no cost or expense call toll free 800.511.7037 or [e-mail]